156 related articles for article (PubMed ID: 3082334)
1. Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions.
Snyder RM; Mirabelli CK; Crooke ST
Biochem Pharmacol; 1986 Mar; 35(6):923-32. PubMed ID: 3082334
[TBL] [Abstract][Full Text] [Related]
2. Cellular interactions of auranofin and a related gold complex with RAW 264.7 macrophages.
Snyder RM; Mirabelli CK; Crooke ST
Biochem Pharmacol; 1987 Mar; 36(5):647-54. PubMed ID: 3827949
[TBL] [Abstract][Full Text] [Related]
3. Biologic actions and pharmacokinetic studies of auranofin.
Walz DT; DiMartino MJ; Griswold DE; Intoccia AP; Flanagan TL
Am J Med; 1983 Dec; 75(6A):90-108. PubMed ID: 6318557
[TBL] [Abstract][Full Text] [Related]
4. The pharmacological profile of auranofin, an orally active gold compound.
Walz DT; DiMartino MJ; Griswold DE
Scand J Rheumatol Suppl; 1983; 51():16-25. PubMed ID: 6426049
[TBL] [Abstract][Full Text] [Related]
5. Triethylphosphine gold: cellular uptake and disposition after single and repeated oral doses in rats.
Sharma RP; Smillie J; Laverty R
J Pharm Pharmacol; 1984 Jul; 36(7):441-5. PubMed ID: 6146687
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of auranofin in animals.
Intoccia AP; Flanagan TL; Walz DT; Gutzait L; Swagzdis JE; Flagiello J; Hwang BY; Dewey RH; Noguchi H
J Rheumatol Suppl; 1982; 8():90-8. PubMed ID: 6813497
[TBL] [Abstract][Full Text] [Related]
7. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
[No Abstract] [Full Text] [Related]
8. Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST).
Furst DE; Dromgoole SH
Clin Rheumatol; 1984 Mar; 3 Suppl 1():17-24. PubMed ID: 6432409
[TBL] [Abstract][Full Text] [Related]
9. Auranofin treatment of rats: adaptation to intestinal adverse effects and observations on the cytosolic distribution of gold in the intestines, liver and kidneys.
Glennås A
Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):404-9. PubMed ID: 3929564
[TBL] [Abstract][Full Text] [Related]
10. Intestinal uptake and metabolism of auranofin, a new oral gold-based antiarthritis drug.
Tepperman K; Finer R; Donovan S; Elder RC; Doi J; Ratliff D; Ng K
Science; 1984 Jul; 225(4660):430-2. PubMed ID: 6429854
[TBL] [Abstract][Full Text] [Related]
11. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
[TBL] [Abstract][Full Text] [Related]
12. Auranofin versus injectable gold. Comparison of pharmacokinetic properties.
Blocka K
Am J Med; 1983 Dec; 75(6A):114-22. PubMed ID: 6419592
[TBL] [Abstract][Full Text] [Related]
13. The cellular and molecular pharmacology of auranofin and related gold complexes.
Crooke ST; Snyder RM
Scand J Rheumatol Suppl; 1986; 63():1-18. PubMed ID: 3474775
[TBL] [Abstract][Full Text] [Related]
14. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
[TBL] [Abstract][Full Text] [Related]
15. [Auranofin (Ridaura). A peroral gold salt].
Manthorpe R
Ugeskr Laeger; 1985 Mar; 147(10):888-90. PubMed ID: 3920800
[No Abstract] [Full Text] [Related]
16. Clinical pharmacokinetics of oral and injectable gold compounds.
Blocka KL; Paulus HE; Furst DE
Clin Pharmacokinet; 1986; 11(2):133-43. PubMed ID: 3082559
[TBL] [Abstract][Full Text] [Related]
17. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
[TBL] [Abstract][Full Text] [Related]
18. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
Batlle Gualda E
Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
[No Abstract] [Full Text] [Related]
19. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
[TBL] [Abstract][Full Text] [Related]
20. Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin.
Griswold DE; Lee JC; Poste G; Hanna N
J Rheumatol; 1985 Jun; 12(3):490-7. PubMed ID: 2931519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
